" HR+ P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer (HR+ Cohort)"
Clinical Trial Grant
Awarded By
Johns Hopkins University
Start Date
September 5, 2024
End Date
October 4, 2025
Awarded By
Johns Hopkins University
Start Date
September 5, 2024
End Date
October 4, 2025